Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 1323, pseudogene (RNU6-1323P)
- Target
- RNU6-1323P
- Molecular classification
- Other (Pseudogene), Small nuclear RNA (snRNA) pseudogene
01
Overview
RNA, U6 small nuclear 1323, pseudogene (RNU6-1323P) is a non-coding RNA pseudogene found in the human genome. It is derived from U6 small nuclear RNA, which plays a crucial role in splicing as part of the spliceosome, but as a pseudogene, RNU6-1323P does not produce a functional RNA product and is not believed to have biological activity. U6 snRNA pseudogenes, including RNU6-1323P, are multiply duplicated genomic elements mainly generated by retrotransposition (especially L1-mediated). They are considered part of the background “genomic fossil” record of small RNA evolution and retrotransposon activity, rather than functional genes. There is no evidence that RNU6-1323P is expressed or has a role in disease, molecular pathways, or therapeutics.
- Other names
- RNU6-1323P
02
Mechanism of action
Not applicable (no drug targets or known molecular function)
03
Biological functions
None (as a pseudogene; the original U6 snRNA is involved in pre-mRNA splicing, but the pseudogene has no known biological function)
04
Disease associations
None establishedU6 snRNA pseudogenes are used as markers of retrotransposition activity but have no direct disease function
05
Safety considerations
None known or relevant
06
Interacting drugs
None known
07
Biomarkers
None (RNU6-1323P itself is not a biomarker; U6 pseudogenes generally are not used clinically, though U6 snRNA is sometimes a control in molecular assays)
Beyond the preview
Go deeper on RNA, U6 small nuclear 1323, pseudogene (RNU6-1323P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U6 small nuclear 1323, pseudogene (RNU6-1323P).